G reen chemistry aims to minimize impact on the environment, but it can also save manufacturers time and money, making it good for the bottom line. Recognizing this, many pharmaceutical companies have shifted toward green processes for drug discovery and development in the past decade. Margaret Faul, a synthetic organic chemist by training, led this move at Amgen, one of the world’s largest bio...
